NF1 and acute lymphoblastic leukemia: Indeed, neurofibromin 1 (NF1), a tumor suppressor protein enhancing RAS hydrolyzing activity, was reported to be mutated in T-ALL patients [151], as well as to have a leukemogenic potential in vivo when deleted in combination with p120-RAS GAP in T-cells [152].